Titusville, NJ, United States of America

Martin D Eastgate

This inventor holds 17 USPTO granted patents and 10 published patent applications and 2 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Scripps Research Institute, Viiv Healthcare UK (No. 4) Limited. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin D Eastgate. Retrieved from https://idiyas.com/inventor/martin-d-eastgate

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 10)

% Patents Active = 88.2

EPO Patents = 2 (Patent Applications = 12)

Average Co-Inventor Count = 9.8

ph-index = 2

Forward Citations = 8(Granted Patents)

Location History:

Trenton, NJ (US) (2014 - 2016)
New Brunswick, NJ (US) (2019)
Titusville, NJ (US) (2016 - 2024)

Company Filing History:

16 out of 3,737

Bristol-Myers Squibb Compnay

patents

3 out of 1,206

Scripps Research Institute

patents

1 out of 8

Viiv Healthcare UK (No. 4) Limited

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12492217 - Reagents and their use for modular enantiodivergent synthesis of C—P bonds (2025-12-09),

2. 12077558 - Phosphorus (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophosphorus (V) compounds (2024-09-03),

3. 12018097 - Non-chromatographic purification of macrocyclic peptides by a resin catch and release (2024-06-25),

4. 11613554 - Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds (2023-03-28),

5. 11479581 - Non-chromatographic purification of macrocyclic peptides by a resin catch and release (2022-10-25),

6. 11254679 - Process for the preparation of N-((1R,2S,5R)-5-(-butylamino)-2-((S)-3-(7--butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamide (2022-02-22),

7. 10221208 - Methods of producing an HIV maturation inhibitor (2019-03-05),

8. 10106560 - Process and intermediates for making tubulysin analogs (2018-10-23),

9. 9518058 - Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide (2016-12-13),

10. 9403821 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound (2016-08-02),

11. 9394322 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound (2016-07-19),

12. 9376458 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound (2016-06-28),

13. 9273067 - Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication (2016-03-01),

14. 9255113 - Methods for the Preparation of HIV attachment inhibitor piperazine prodrug compound (2016-02-09),

15. 9249168 - Methods for the preparation of HIV attachment inhibitor piperazine prodrug compound (2016-02-02),

Title: The Innovative Mind of Martin D Eastgate

Introduction: Martin D Eastgate, a distinguished inventor hailing from Titusville, NJ (US), is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Martin D Eastgate holds several patents in the realm of renewable energy technologies, including a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the industry, Martin D Eastgate has worked with leading tech companies to develop cutting-edge solutions. His expertise in sustainable energy solutions has earned him accolades globally.

Collaborations: Throughout his career, Martin D Eastgate has collaborated with top researchers and engineers to push the boundaries of innovation. His collaborative projects have resulted in patents that have transformed the renewable energy sector.

Conclusion: Martin D Eastgate's passion for innovation and commitment to sustainability continue to drive his work forward, making him a key figure in the world of technological advancements.

Profile summary based on public USPTO records.